This report was recently updated on July 20 2024 with the latest and most recent
market numbers
Global Implantable Defibrillators Market Size, Trends & Analysis - Forecasts to 2029 By Type (Transvenous Implantable Cardioverter-Defibrillators [T-ICDs], Subcutaneous Implantable Cardioverter Defibrillators [S-ICDs], and Cardiac Resynchronization Therapy Defibrillators [CRT-D]), By Application Type (Hospitals, Ambulatory Surgical Centers, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global implantable defibrillators market is expected to exhibit a CAGR of 6.5% from 2024 to 2029.
The implantable cardioverter defibrillator (ICD) is an electronic medical device utilized for monitoring and regulating heart rhythms in individuals susceptible to life-threatening arrhythmias such as ventricular tachycardia (VT) and ventricular fibrillation (VF). The market growth is propelled by various factors, including technological advancements, the escalating incidence of sudden cardiac arrest, increasing public awareness, and supportive policies implemented by governments and healthcare organizations. Moreover, the market benefits from the innovation endeavors of emerging players. For instance, in July 2022, MicroPort Scientific Corporation obtained a CE mark for its INVICTA line of defibrillation leads, showcasing ongoing developments in the sector. With the growing prevalence of cardiovascular diseases (CVDs), there is a rising demand for advanced cardiac care solutions, including ICDs, which is anticipated to foster opportunities for expansion and advancements in the healthcare domain.
The global market for implantable defibrillators, encompassing Implantable cardioverter defibrillators (ICD) and other implantable cardioverter therapy devices, is witnessing significant growth attributed to advancements in implantable defibrillator technology and rising demand for cardiac rhythm management devices. As a vital component of sudden cardiac arrest treatment and cardiac arrhythmia management, implantable defibrillators play a crucial role in safeguarding patients at risk of life-threatening heart rhythms. The market for implantable cardioverter defibrillator brands is expanding rapidly, driven by an increasing number of defibrillator implantation procedures worldwide. Implantable defibrillator systems and cardiac resynchronization therapy devices are at the forefront of innovative solutions in the implantable medical devices market, offering enhanced capabilities for heart rhythm monitoring and treatment.
Furthermore, the surge in demand for implantable heart rhythm devices is propelling growth in the electrophysiology devices market, with implantable defibrillator manufacturers investing heavily in research and development to introduce technologically advanced products. Defibrillator lead systems are witnessing significant improvements, enhancing the efficacy and reliability of implantable defibrillator technology. With the continuous evolution of implantable heart monitoring devices, patients are benefiting from enhanced diagnostic capabilities and improved treatment outcomes. Overall, the implantable defibrillator device market is poised for substantial expansion, driven by increasing awareness of sudden cardiac arrest risks and the growing adoption of implantable cardiac devices for comprehensive cardiac arrhythmia treatment and management.
The ICD market is categorized based on product type into transvenous implantable cardioverter-defibrillators (T-ICDs), cardiac resynchronization therapy defibrillator (CRT-D), and subcutaneous implantable cardioverter defibrillator segments (S-ICDs). In 2023, the T-ICDs segment emerged as the leading segment, accounting for a significant revenue share. This dominance stems from the advantages offered by T-ICDs in managing life-threatening ventricular arrhythmias, along with their ability to mitigate procedural complications and reduce medical costs associated with invasive surgeries. T-ICDs effectively address the needs of patients with ventricular fibrillation (VF) and ventricular tachycardia (VT) through features such as cardiac resynchronization therapy (CRT), permanent pacing, and anti-tachycardia pacing.
Conversely, the S-ICDs segment is anticipated to exhibit the fastest compound annual growth rate (CAGR) throughout the forecast period. This projected growth can be attributed to the effectiveness of S-ICDs in treating ventricular heart disease and mitigating the risk of sudden cardiac arrest (SCA). S-ICDs offer distinct advantages over traditional T-ICDs by minimizing complications and perioperative issues. Particularly beneficial for patients with complex anatomies or those unsuitable for endovascular lead implantation, S-ICDs have demonstrated lower rates of major lead-related complications in clinical trials.
As of 2023, the hospitals segment has emerged as the leading segment.. Several factors underpin this dominance. Firstly, hospitals are renowned for providing superior patient care, making them the preferred choice for medical procedures, including defibrillator implantations. With the anticipated rise in cardiovascular disease cases, hospitals are poised to witness substantial growth in defibrillator implantations. The presence of skilled cardiologists and well-equipped facilities further bolsters the dominance of this segment. Moreover, the availability of comprehensive reimbursement facilities and ease of access to treatment attract an increasing number of patients to hospitals. The variation in implantation types across different hospitals underscores the pivotal role of the hospital segment in the market landscape.
The ambulatory surgical center (ASC) segment is expected to witness significant growth during the forecast period. This growth trajectory is attributed to evolving regulatory guidelines, reimbursement scenarios, and governmental efforts to enhance patient care in developed nations. ASCs offer efficient care and low-cost treatment options, aligning with changing patient preferences and healthcare trends, thus driving their adoption and growth in the market.
In 2023, North America emerged as the dominant region in the global market. The region features a well-established, advanced healthcare infrastructure comprising hospitals, clinics, and medical facilities. Moreover, North America grapples with a notably high prevalence of cardiovascular diseases (CVD), including hypertension, necessitating the widespread use of implantable defibrillators. The presence of key market players such as Medtronic, Abbott, and Boston Scientific Corporation further fortifies the market landscape, with Medtronic's introduction of extravascular ICDs (EV-ICDs) opening promising avenues. The clinical effectiveness of EV-ICDs in managing ventricular arrhythmias and tachycardia, compared to traditional transvenous ICDs (T-ICDs) and subcutaneous ICDs (S-ICDs), significantly contributes to the market's growth potential.
Asia Pacific is anticipated to witness the fastest growth over the forecast period. This growth trajectory is attributed to the substantial prevalence of cardiovascular diseases in countries such as China, India, and Japan, driving an escalating demand for cardiology medical devices, including ICDs, for diagnostic and therapeutic purposes. The significant burden of CVD and associated mortalities underscore the pressing need for advanced technologies in this region. Furthermore, companies based in China, India, and Japan are actively engaged in developing and introducing innovative solutions to address the healthcare challenges, fueling the expansion of the Asia Pacific market.
Abbott, Biotronik SE & Co. KG, Boston Scientific Corporation, Fukuda Denshi Co. Ltd., Imricor Medical Systems, Koninklijke Philips N.V., LivaNova Plc Company, Medtronic Plc, Microport scientific corporation, and Nihon Kohden Corporation, among others, are some of the key players operating in the global market.
Please note: This is not an exhaustive list of companies profiled in the report.
In February 2024, patients at Royal Papworth Hospital NHS Foundation Trust were among the pioneering recipients of a groundbreaking implantable cardioverter-defibrillator (ICD) technology. Representing a landmark achievement in European healthcare, John from Newmarket and Gemma from Nottinghamshire became the inaugural recipients outside of clinical trials to receive the Medtronic Extravascular Implantable Cardioverter-Defibrillator (Aurora EV-ICD) system. This cutting-edge innovation marks a pivotal advancement in the treatment of abnormal heart rhythms and the prevention of sudden cardiac arrest, offering renewed hope and improved outcomes for patients at elevated risk.
In June 2023, BIOTRONIK SE & Co. KG announced a strategic partnership with Koninklijke Philips N.V. to broaden the latter's reach in cardiovascular devices. Through this partnership, Koninklijke Philips N.V. gained enhanced access to BIOTRONIK's extensive portfolio of cardiovascular solutions. Philips SymphonySuite emerged as the flagship offering, empowering cardiovascular care delivery within Ambulatory Surgery Centers (ASCs) and office-based labs. This partnership signifies a concerted effort to bolster patient-centric care delivery models, leveraging cutting-edge technologies to optimize cardiovascular diagnosis and treatment in outpatient settings.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
2.4 Data Metrics on Feed Stocks
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY TYPE
4.1 Introduction
4.2 Implantable Defibrillators Market: Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Transvenous Implantable Cardioverter-Defibrillator [T-ICDs]
4.4.1 Transvenous Implantable Cardioverter-Defibrillator [T-ICDs] Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Subcutaneous Implantable Cardioverter Defibrillators [S-ICDS]
4.5.1 Subcutaneous Implantable Cardioverter Defibrillators [S-ICDS] Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Cardiac Resynchronization Therapy Defibrillator [CRT-D]
4.6.1 Cardiac Resynchronization Therapy Defibrillator [CRT-D] Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY APPLICATION
5.1 Introduction
5.2 Implantable Defibrillators Market: Application Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Hospitals
5.4.1 Hospitals Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Ambulatory Surgical Centers
5.5.1 Ambulatory Surgical Centers Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Others
5.6.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY REGION
6.1 Introduction
6.2 North America Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Type
6.2.2 By Application
6.2.3 By Country
6.2.3.1 U.S. Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Type
6.2.3.1.2 By Application
6.2.3.2 Canada Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Type
6.2.3.2.2 By Application
6.2.3.3 Mexico Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Type
6.2.3.3.2 By Application
6.3 Europe Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Type
6.3.2 By Application
6.3.3 By Country
6.3.3.1 Germany Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Type
6.3.3.1.2 By Application
6.3.3.2 U.K. Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Type
6.3.3.2.2 By Application
6.3.3.3 France Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Type
6.3.3.3.2 By Application
6.3.3.4 Italy Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Type
6.3.3.4.2 By Application
6.3.3.5 Spain Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Type
6.3.3.5.2 By Application
6.3.3.6 Netherlands Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Type
6.3.3.6.2 By Application
6.3.3.7 Rest of Europe Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Type
6.3.3.6.2 By Application
6.4 Asia Pacific Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Type
6.4.2 By Application
6.4.3 By Country
6.4.3.1 China Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Type
6.4.3.1.2 By Application
6.4.3.2 Japan Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Type
6.4.3.2.2 By Application
6.4.3.3 India Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Type
6.4.3.3.2 By Application
6.4.3.4 South Korea Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Type
6.4.3.4.2 By Application
6.4.3.5 Singapore Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Type
6.4.3.5.2 By Application
6.4.3.6 Malaysia Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Type
6.4.3.6.2 By Application
6.4.3.7 Thailand Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Type
6.4.3.6.2 By Application
6.4.3.8 Indonesia Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Type
6.4.3.7.2 By Application
6.4.3.9 Vietnam Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Type
6.4.3.8.2 By Application
6.4.3.10 Taiwan Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Type
6.4.3.10.2 By Application
6.4.3.11 Rest of Asia Pacific Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Type
6.4.3.11.2 By Application
6.5 Middle East and Africa Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Type
6.5.2 By Application
6.5.3 By Country
6.5.3.1 Saudi Arabia Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Type
6.5.3.1.2 By Application
6.5.3.2 U.A.E. Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Type
6.5.3.2.2 By Application
6.5.3.3 Israel Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Type
6.5.3.3.2 By Application
6.5.3.4 South Africa Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Type
6.5.3.4.2 By Application
6.5.3.5 Rest of Middle East and Africa Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Type
6.5.3.5.2 By Application
6.6 Central & South America Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Type
6.6.2 By Application
6.6.3 By Country
6.6.3.1 Brazil Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Type
6.6.3.1.2 By Application
6.6.3.2 Argentina Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Type
6.6.3.2.2 By Application
6.6.3.3 Chile Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Type
6.6.3.3.2 By Application
6.6.3.3 Rest of Central & South America Implantable Defibrillators Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Type
6.6.3.3.2 By Application
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Abbott
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Biotronik SE & Co. KG
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Boston Scientific Corporation
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Fukuda Denshi Co. Ltd.
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 Imricor Medical Systems
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 Koninklijke Philips N.V.
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 LivaNova Plc Company
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Medtronic Plc
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Microport Scientific Corporation
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Nihon Kohden Corporation
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 InApplicationation Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company InApplicationation Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
2 Transvenous Implantable Cardioverter-Defibrillator [T-ICDs] Market, By Region, 2021-2029 (USD Million)
3 Subcutaneous Implantable Cardioverter Defibrillators [S-ICDS] Market, By Region, 2021-2029 (USD Million)
4 Cardiac Resynchronization Therapy Defibrillator [CRT-D] Market, By Region, 2021-2029 (USD Million)
5 Global Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
6 Hospitals Market, By Region, 2021-2029 (USD Million)
7 Ambulatory Surgical Centers Market, By Region, 2021-2029 (USD Million)
8 Others Market, By Region, 2021-2029 (USD Million)
9 Regional Analysis, 2021-2029 (USD Million)
10 North America Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
11 North America Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
12 North America Implantable Defibrillators Market, By Country, 2021-2029 (USD Million)
13 U.S. Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
14 U.S. Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
15 Canada Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
16 Canada Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
17 Mexico Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
18 Mexico Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
19 Europe Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
20 Europe Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
21 Europe Implantable Defibrillators Market, By Country, 2021-2029 (USD Million)
22 Germany Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
23 Germany Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
24 U.K. Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
25 U.K. Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
26 France Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
27 France Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
28 Italy Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
29 Italy Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
30 Spain Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
31 Spain Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
32 Netherlands Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
33 Netherlands Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
34 Rest Of Europe Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
35 Rest Of Europe Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
36 Asia Pacific Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
37 Asia Pacific Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
38 Asia Pacific Implantable Defibrillators Market, By Country, 2021-2029 (USD Million)
39 China Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
40 China Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
41 Japan Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
42 Japan Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
43 India Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
44 India Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
45 South Korea Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
46 South Korea Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
47 Singapore Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
48 Singapore Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
49 Thailand Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
50 Thailand Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
51 Malaysia Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
52 Malaysia Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
53 Indonesia Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
54 Indonesia Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
55 Vietnam Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
56 Vietnam Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
57 Taiwan Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
58 Taiwan Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
59 Rest of APAC Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
60 Rest of APAC Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
61 Middle East and Africa Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
62 Middle East and Africa Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
63 Middle East and Africa Implantable Defibrillators Market, By Country, 2021-2029 (USD Million)
64 Saudi Arabia Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
65 Saudi Arabia Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
66 UAE Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
67 UAE Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
68 Israel Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
69 Israel Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
70 South Africa Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
71 South Africa Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
72 Rest Of Middle East and Africa Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
73 Rest Of Middle East and Africa Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
74 Central & South America Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
75 Central & South America Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
76 Central & South America Implantable Defibrillators Market, By Country, 2021-2029 (USD Million)
77 Brazil Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
78 Brazil Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
79 Chile Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
80 Chile Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
81 Argentina Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
82 Argentina Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
83 Rest Of Central & South America Implantable Defibrillators Market, By Type, 2021-2029 (USD Million)
84 Rest Of Central & South America Implantable Defibrillators Market, By Application, 2021-2029 (USD Million)
85 Abbott: Products & Services Offering
86 Biotronik SE & Co. KG: Products & Services Offering
87 Boston Scientific Corporation: Products & Services Offering
88 Fukuda Denshi Co. Ltd.: Products & Services Offering
89 Imricor Medical Systems: Products & Services Offering
90 Koninklijke Philips N.V.: Products & Services Offering
91 LivaNova Plc Company : Products & Services Offering
92 Medtronic Plc: Products & Services Offering
93 Microport Scientific Corporation, Inc: Products & Services Offering
94 Nihon Kohden Corporation: Products & Services Offering
95 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Implantable Defibrillators Market Overview
2 Global Implantable Defibrillators Market Value From 2021-2029 (USD Million)
3 Global Implantable Defibrillators Market Share, By Type (2023)
4 Global Implantable Defibrillators Market Share, By Application (2023)
5 Global Implantable Defibrillators Market, By Region (Global Market)
6 Technological Trends In Global Implantable Defibrillators Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Implantable Defibrillators Market
10 Impact Of Challenges On The Global Implantable Defibrillators Market
11 Porter’s Five Forces Analysis
12 Global Implantable Defibrillators Market: By Type Scope Key Takeaways
13 Global Implantable Defibrillators Market, By Type Segment: Revenue Growth Analysis
14 Transvenous Implantable Cardioverter-Defibrillator [T-ICDs] Market, By Region, 2021-2029 (USD Million)
15 Subcutaneous Implantable Cardioverter Defibrillators [S-ICDS] Market, By Region, 2021-2029 (USD Million)
16 Cardiac Resynchronization Therapy Defibrillator [CRT-D] Market, By Region, 2021-2029 (USD Million)
17 Global Implantable Defibrillators Market: By Application Scope Key Takeaways
18 Global Implantable Defibrillators Market, By Application Segment: Revenue Growth Analysis
19 Hospitals Market, By Region, 2021-2029 (USD Million)
20 Ambulatory Surgical Centers Market, By Region, 2021-2029 (USD Million)
21 Others Market, By Region, 2021-2029 (USD Million)
22 Regional Segment: Revenue Growth Analysis
23 Global Implantable Defibrillators Market: Regional Analysis
24 North America Implantable Defibrillators Market Overview
25 North America Implantable Defibrillators Market, By Type
26 North America Implantable Defibrillators Market, By Application
27 North America Implantable Defibrillators Market, By Country
28 U.S. Implantable Defibrillators Market, By Type
29 U.S. Implantable Defibrillators Market, By Application
30 Canada Implantable Defibrillators Market, By Type
31 Canada Implantable Defibrillators Market, By Application
32 Mexico Implantable Defibrillators Market, By Type
33 Mexico Implantable Defibrillators Market, By Application
34 Four Quadrant Positioning Matrix
35 Company Market Share Analysis
36 Abbott: Company Snapshot
37 Abbott: SWOT Analysis
38 Abbott: Geographic Presence
39 Biotronik SE & Co. KG: Company Snapshot
40 Biotronik SE & Co. KG: SWOT Analysis
41 Biotronik SE & Co. KG: Geographic Presence
42 Boston Scientific Corporation: Company Snapshot
43 Boston Scientific Corporation: SWOT Analysis
44 Boston Scientific Corporation: Geographic Presence
45 Fukuda Denshi Co. Ltd.: Company Snapshot
46 Fukuda Denshi Co. Ltd.: Swot Analysis
47 Fukuda Denshi Co. Ltd.: Geographic Presence
48 Imricor Medical Systems: Company Snapshot
49 Imricor Medical Systems: SWOT Analysis
50 Imricor Medical Systems: Geographic Presence
51 Koninklijke Philips N.V.: Company Snapshot
52 Koninklijke Philips N.V.: SWOT Analysis
53 Koninklijke Philips N.V.: Geographic Presence
54 LivaNova Plc Company : Company Snapshot
55 LivaNova Plc Company : SWOT Analysis
56 LivaNova Plc Company : Geographic Presence
57 Medtronic Plc: Company Snapshot
58 Medtronic Plc: SWOT Analysis
59 Medtronic Plc: Geographic Presence
60 Microport Scientific Corporation, Inc.: Company Snapshot
61 Microport Scientific Corporation, Inc.: SWOT Analysis
62 Microport Scientific Corporation, Inc.: Geographic Presence
63 Nihon Kohden Corporation: Company Snapshot
64 Nihon Kohden Corporation: SWOT Analysis
65 Nihon Kohden Corporation: Geographic Presence
66 Other Companies: Geographic Presence
67 Other Companies: Company Snapshot
68 Other Companies: SWOT Analysis
The Global Implantable Defibrillators Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Implantable Defibrillators Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
![Global Implantable Defibrillators Market Size, Trends & Analysis - Forecasts to 2029 By Type (Transvenous Implantable Cardioverter-Defibrillators [T-ICDs], Subcutaneous Implantable Cardioverter Defibrillators [S-ICDs], and Cardiac Resynchronization Therapy Defibrillators [CRT-D]), By Application Type (Hospitals, Ambulatory Surgical Centers, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis](https://www.globalmarketestimates.com/images/cat/Healthcare.png)
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
